POMDOCTOR Ltd (POM)
$0.75+20.97%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 2.28
- P/E (TTM)
- -1.36
- Short % float
- 16.51%
- Days to cover
- 1.1
- SI change
- +42.1%
- 1W
- -25.74%
- 1M
- +5.63%
- vs SPY 1W
- -25.60%
- vs SPY 1M
- +3.13%
Industry peers
FMP comparable companies · ranked by market cap
- ERASSELLErasca, Inc.$5.6BRECOVERYQ 4$16.03-4.40%
- INNVSELLInnovage Holding Corp.$1.2BCRISISQ 13$9.10-1.42%
- SIBNBUYSI-BONE, Inc.$859MBULLQ 5$19.37-2.09%
- PACBBUYPacific Biosciences of California, Inc.$724MCRISISQ 4$2.33-2.38%
- FLGTSELLFulgent Genetics, Inc.$617MRECOVERYQ 13$21.74-1.91%
- AQSTSELLAquestive Therapeutics, Inc.$600MRECOVERYQ -4$4.78-2.91%
- CTMXSELLCytomX Therapeutics, Inc.$559MCRISISQ 6$2.57-3.72%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on POM?
- LOPJLB’s latest quantitative signal on POMDOCTOR Ltd (POM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is POM in?
- POMDOCTOR Ltd (POM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does POMDOCTOR Ltd (POM) do?
- Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a…